Next Article in Journal
Monitoring Early Changes in Tumor Metabolism in Response to Therapy Using Hyperpolarized 13C MRSI in a Preclinical Model of Glioma
Previous Article in Journal
Co-Clinical Imaging Resource Program (CIRP): Bridging the Translational Divide to Advance Precision Medicine
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Tomography
Volume 6
Issue 3
10.18383/j.tom.2020.00030
tomography-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Tomography is published by MDPI from Volume 7 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Grapho, LLC.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Dedicated Verification of an Accessory Parotid Gland via Minimal-Activity PSMA-PET/CT

by
Falk Gühne
1,
Robert Drescher
1,
René Aschenbach
2,
Philipp Seifert
1 and
Martin Freesmeyer
1,*
1
Clinic of Nuclear Medicine, Jena University Hospital, 07747 Jena, Germany
2
Institute of Diagnostic and Interventional Radiology, Jena University Hospital, 07747 Jena, Germany
*
Author to whom correspondence should be addressed.
Tomography 2020, 6(3), 288-289; https://doi.org/10.18383/j.tom.2020.00030
Submission received: 6 June 2020 / Revised: 4 July 2020 / Accepted: 3 August 2020 / Published: 1 September 2020
Versions Notes

Abstract

Gallium-68-labeled prostate-specific membrane antigen ligands are not only established radiopharmaceuticals for staging of prostate cancer but also accumulate physiologically in nonprostate organs, including the salivary glands. We show the converted application of prostate-specific membrane antigen -positron emission tomography/computed tomography (PSMA-PET/CT) as a dedicated method to depict salivary gland tissue using a region-focused, low-dose protocol. An accessory parotid gland at the right buccal region could be confirmed; therefore, further diagnostic or invasive therapeutic steps were not necessary.
Keywords: minimal-activity protocol; PSMA-PET/CT; salivary glands minimal-activity protocol; PSMA-PET/CT; salivary glands

Share and Cite

MDPI and ACS Style

Gühne, F.; Drescher, R.; Aschenbach, R.; Seifert, P.; Freesmeyer, M. Dedicated Verification of an Accessory Parotid Gland via Minimal-Activity PSMA-PET/CT. Tomography 2020, 6, 288-289. https://doi.org/10.18383/j.tom.2020.00030

AMA Style

Gühne F, Drescher R, Aschenbach R, Seifert P, Freesmeyer M. Dedicated Verification of an Accessory Parotid Gland via Minimal-Activity PSMA-PET/CT. Tomography. 2020; 6(3):288-289. https://doi.org/10.18383/j.tom.2020.00030

Chicago/Turabian Style

Gühne, Falk, Robert Drescher, René Aschenbach, Philipp Seifert, and Martin Freesmeyer. 2020. "Dedicated Verification of an Accessory Parotid Gland via Minimal-Activity PSMA-PET/CT" Tomography 6, no. 3: 288-289. https://doi.org/10.18383/j.tom.2020.00030

Article Metrics

Back to TopTop